Related Experiment Video
Updated: Jun 26, 2026

10:03
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
16.9K
Lassa Fever: Critical Review and Prospects for Control
Marianne E Besson1, Michel Pépin2, Pierre-Alexandre Metral3
1Department of Public Health, Royal Veterinary College, London NW1 0TU, UK.
Tropical Medicine and Infectious Disease
|August 28, 2024
Summary
Lassa Fever, a deadly zoonotic disease in West Africa, requires urgent global attention due to increasing cases and fatality rates. A
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Lassa Fever is a severe viral hemorrhagic disease endemic to West Africa, causing significant mortality.
- Transmission occurs through rodents (genus Mastomys) and secondary human-to-human contact.
- The disease is characterized by endemicity and epidemic outbreaks, with no licensed vaccine or effective treatment.
Purpose of the Study:
- To provide an overview of Lassa Fever, with a focus on Nigeria.
- To discuss current challenges in disease control and prevention.
- To highlight the need for a 'One Health' approach.
Main Methods:
- Review of existing literature on Lassa Fever epidemiology and control.
- Analysis of disease transmission dynamics and contributing factors.
- Discussion of scientific and socio-economic barriers to vaccine and treatment development.
Main Results:
- Incomplete epidemiological data and inadequate surveillance hinder disease management.
- Viral genetic diversity and lack of understanding of immune protection complicate vaccine development.
- Socio-economic factors and limited research incentives perpetuate the disease in vulnerable communities.
Conclusions:
- Lassa Fever poses an increasing international threat, necessitating global collaboration for control.
- Development of medical countermeasures and public health policies is crucial.
- A comprehensive 'One Health' strategy integrating animal, human, and environmental health is essential for effective Lassa Fever management.
Related Concept Videos
Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
Patterns of Fever
Before understanding the types and patterns of fever, it is essential to know its phases.
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

